This table presents recent patent oppositions filed by Ipsen Biopharm Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3094331Combination-Based Treatment MethodNEKTAR THERAPEUTICSSep 27, 2018

The following table provides an overview of the latest patents of Ipsen Biopharm Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2939688Feb 20, 2019Pharmaceutical Compositions Comprising Botulinum Neurotoxin1